Global Neonate Bilirubin Phototherapy Equipment Market Growth 2025-2031

The global Neonate Bilirubin Phototherapy Equipment market size is predicted to grow from US$ 256 million in 2025 to US$ 304 million in 2031; it is expected to grow at a CAGR of 2.9% from 2025 to 2031.

Jaundice (Hyperbilirubinemia) is a common condition, particularly in pre-mature babies worldwide. The skin of the newborn baby becomes jaundiced (baby’s skin and Sclerae appear yellow) which is caused by a high level of bilirubin in the blood. Bilirubin is a waste product, produced when red blood cells are broken down. It is normally broken down in the liver and removed from the body in the stool. However, an underdeveloped liver of infant cannot filter out the bilirubin as fast as it i being produced, resulting in hyperbilirubinemia (Jaundice). If untreated the levels of bilirubin may rise high enough to pass through the blood brain barrier and is deposited in the brain causing Kernicterus and brain damage. Phototherapy is a treatment with special type of light (wavelength range 420 to 480nm) which lower bilirubin level in neonatal, the process is called photo-oxidation in which light wave converts the bilirubin to water soluble non-toxic form, make it easier for baby’s liver to break down and remove the bilirubin from their blood.

The market driver for Neonate Bilirubin Phototherapy Equipment is the increasing prevalence of neonatal jaundice and the growing awareness of the importance of early and effective treatment to manage this condition. Neonate Bilirubin Phototherapy Equipment is specialized medical equipment used to treat neonatal jaundice, a common condition in newborn babies caused by the accumulation of bilirubin in the blood. Several factors contribute to the growing demand for Neonate Bilirubin Phototherapy Equipment in the market:

Prevalence of Neonatal Jaundice: Neonatal jaundice is one of the most common medical conditions in newborns, affecting a significant number of infants worldwide.

Impact on Neonatal Health: Untreated or poorly managed neonatal jaundice can lead to serious complications, including kernicterus and neurological damage. Phototherapy is an effective treatment to prevent these complications.

Non-Invasive Treatment: Bilirubin phototherapy is a non-invasive treatment that reduces the need for more invasive procedures, such as blood transfusions, in neonates with jaundice.

Medical Advancements and Technology: Advances in medical technology and phototherapy equipment design have improved the efficiency and effectiveness of neonate bilirubin phototherapy.

Rising Awareness: Increased awareness among healthcare providers and parents about the importance of early diagnosis and treatment of neonatal jaundice drives the demand for phototherapy equipment.

Improved Neonatal Care Facilities: Expanding neonatal care facilities, particularly in developing regions, create a higher demand for neonate bilirubin phototherapy equipment.

Government Initiatives: Government initiatives and healthcare programs focusing on newborn health and well-being contribute to the adoption of neonate bilirubin phototherapy equipment.

Technological Advancements: Ongoing advancements in phototherapy technology, such as the development of LED-based phototherapy devices, drive the adoption of newer and more efficient equipment.

Hospital and NICU Investments: Hospitals and neonatal intensive care units (NICUs) invest in advanced neonate bilirubin phototherapy equipment to enhance the quality of neonatal care.

Growing Preterm Births: Preterm infants are more susceptible to neonatal jaundice, leading to an increased demand for neonate bilirubin phototherapy equipment.

LP Information, Inc. (LPI) ' newest research report, the “Neonate Bilirubin Phototherapy Equipment Industry Forecast” looks at past sales and reviews total world Neonate Bilirubin Phototherapy Equipment sales in 2024, providing a comprehensive analysis by region and market sector of projected Neonate Bilirubin Phototherapy Equipment sales for 2025 through 2031. With Neonate Bilirubin Phototherapy Equipment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neonate Bilirubin Phototherapy Equipment industry.

This Insight Report provides a comprehensive analysis of the global Neonate Bilirubin Phototherapy Equipment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neonate Bilirubin Phototherapy Equipment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neonate Bilirubin Phototherapy Equipment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neonate Bilirubin Phototherapy Equipment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neonate Bilirubin Phototherapy Equipment.

This report presents a comprehensive overview, market shares, and growth opportunities of Neonate Bilirubin Phototherapy Equipment market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Contact Type
Contactless Type

Segmentation by Application:
Hospitals
Confinement Centers
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GE Healthcare
Weyer GmbH
Delta Medical International
Natus Medical Incorporated
Medicor
Drager
Zeal Medical
MTTS
David Medical Device
BEING MEDICAL DEVICE
BIOBASE
Julongsanyou Technology
Phoenix Medical Systems
Ibis Medical
Apothecaries Sundries Manufacturing

Key Questions Addressed in this Report

What is the 10-year outlook for the global Neonate Bilirubin Phototherapy Equipment market?

What factors are driving Neonate Bilirubin Phototherapy Equipment market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Neonate Bilirubin Phototherapy Equipment market opportunities vary by end market size?

How does Neonate Bilirubin Phototherapy Equipment break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.